Olaf Reich - Gynecology

Author Information

Olaf Reich is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at the Medical University of Graz, Graz, Austria. His work primarily focuses on gynecologic oncology, with a significant emphasis on cervical cancer and related precancerous conditions.

Research Contributions

Olaf Reich has made substantial contributions to the field of gynecology, particularly in the study of human papillomavirus (HPV) and its role in cervical cancer. His research includes investigations into HPV-independent cervical cancers, the efficacy of topical treatments versus surgical interventions for vulvar intraepithelial neoplasia, and the origin of cervical squamous cancer. Notably, his work also explores the diagnostic challenges associated with high-grade squamous intraepithelial lesions and the prognostic significance of driver gene mutations in micro-invasive cervical cancers.

Aliases

Olaf Reich is also known by the aliases O Reich and O. Reich.

Publication and Citation Metrics

Metric	Value
Citation Count	3261
h-index	28
Paper Count	167

Publications:

Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes et al

DOI: 10.1136/ijgc-2022-003368

Year: 2022

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial

DOI: 10.1016/S0140-6736(22)00469-X

Year: 2022

Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.

DOI: 10.1016/j.ygyno.2022.01.033

Year: 2022

Thin High-Grade Squamous Intraepithelial Lesions Are Often Missed or Misinterpreted in Cytology and Histology.

DOI: 10.1093/ajcp/aqac049

Year: 2022

Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.

DOI: 10.1016/j.ygyno.2022.01.020

Year: 2022

The origin of Human Papillomavirus (HPV) - induced cervical squamous cancer.

DOI: 10.1016/j.coviro.2021.09.012

Year: 2021

Cervical Precancers Originate From Infected Proliferating Reserve Cells

DOI: 10.1097/PAS.0000000000001818

Year: 2021

Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study.

DOI: 10.1016/j.vaccine.2021.01.074

Year: 2021

100 years of iodine testing of the cervix: A critical review and implications for the future.

DOI: 10.1016/j.ejogrb.2021.04.011

Year: 2021

HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions

DOI: 10.1097/PAS.0000000000001778

Year: 2021

How Can Physical Comfort Be Ensured?

What treatments are available for conditions causing a bluish or purple hue?

Are Out-of-Network Providers Covered?

How Do Heart Valve Disorders Affect Pregnancy?

What Services Are Provided?

What Causes Ingrown Hairs?

What Role Do Universities and Institutions Play?

What Training Resources Are Available for Gynecology Coders?

What Role Do Wearable Devices Play in Gynecology?

How to Care for the Incision Site?

Partnered Content Networks

Relevant Topics